Peptide LexiconAll compounds

Gramicidin: The 1939 Soil-Bacterium Antibiotic That Became the Textbook Ion Channel

Gramicidin is a family of short peptide antibiotics from the soil bacterium found by René Dubos in 1939. Gramicidin A is 15 amino acids that alternate between left- and right-handed forms and pairs up into a channel through cell membranes. It survives in medicine as one of three antibiotics in a prescription eye drop, and in research as a model ion channel.

Approved as a combination eye drop (US)Topical onlyPrescription only

Caroline S · Published 2026-11-17

Length

Gramicidin A: 15 amino acids, linear — C99H140N20O17, molecular weight 1,882.3 (PubChem CID 16132269)

Sequence

formyl-Val-Gly-Ala-Leu-Ala-Val-Val-Val-Trp-Leu-Trp-Leu-Trp-Leu-Trp-ethanolamine, alternating L- and D-amino acids (gramicidin A; stereochemistry per the PubChem name)

Origin

Made by a soil bacillus; first extracted by René Dubos at the Rockefeller Institute in 1939

Last reviewed

2026-11-17

What is it good for?

Gramicidin kills Gram-positive bacteria by making their membranes leak. Its medical use is topical: in the United States it is one of three antibiotics in a prescription eye solution for superficial infections of the eye and eyelid. In laboratories it is used as a model of how ion channels work.

Illustration: Two intertwined white helix molecular models of peptide chains on a white surface with green and copper.
Illustration

What it is

Gramicidin is an antibiotic made of a short peptide chain, produced by a soil bacterium. In 1939 René Dubos, at the Hospital of the Rockefeller Institute, reported isolating a Gram-positive, spore-forming soil bacillus whose cultures released a soluble agent that killed every Gram-positive species tested and was ineffective against all the Gram-negative bacilli tested (Dubos 1939, J Exp Med, PMID 19870884). That agent became tyrothricin, and its two components gramicidin and tyrocidine — the names Dubos himself used in a 1959 retrospective, Tyrothricin, gramicidin, and tyrocidine — twenty years later (PMID 13818331).

The natural product is a mixture — gramicidin A, B and C — often sold as gramicidin D. Gramicidin A is the main component:

Property Gramicidin A Gramicidin S Source
Shape Linear chain Closed ring PubChem
Length 15 amino acids 10 amino acids PubChem
Formula C99H140N20O17 C60H92N12O10 PubChem CIDs 16132269, 73357
Molecular weight 1,882.3 1,141.4 PubChem
Ends Formyl group at the start, ethanolamine at the end None — it is a ring PubChem name

The unusual feature is the alternating handedness. Amino acids in most proteins are all the left-handed (L) form. In gramicidin A, the PubChem chemical name assigns the residues alternately to L and D forms along the chain — formyl-Val, Gly, Ala, then D-Leu, L-Ala, D-Val and so on to four tryptophans near the end. A chain built this way can coil into a helix with a hollow core, which is what makes a channel possible.

Gramicidin S is a different molecule with a confusingly similar name: a 10-residue ring with its own formula, now studied mainly as a template for new antibiotic analogues (reviews of 2019 and 2025, PMIDs 30938996, 40683145). It belongs in a separate record, and nothing on this page about gramicidin A should be read across to it.

How it works

Two gramicidin A molecules join across a cell membrane to form the working channel — solid-state NMR work on the "gramicidin A channel dimer" in hydrated lipid membranes is one line of that evidence (PMID 10805133). A 2007 review describes the result as a prototypical ion channel specific for monovalent cations — sodium, potassium, hydrogen ions — and notes it has been "extensively used" to study how membrane channels are organised and how they work (Kelkar and Chattopadhyay, Biochim Biophys Acta, PMID 17572379). The review's own point is that crystal structures of large natural channels have since challenged gramicidin's role as the model, while its tryptophans remain a reference for how channels anchor in a membrane.

Its medical use is topical only, on the label described below. Tonight's sources do not quantify toxicity to human cells, so this entry gives no figure for it.

In medicine today

The one current US product found in Drugs@FDA is a prescription eye solution combining three antibiotics (ANDA 064047, Bausch & Lomb; label effective 2026-02-04). The label lists, per mL:

Ingredient Amount per mL
Neomycin sulfate equivalent to 1.75 mg neomycin base
Polymyxin B sulfate 10,000 polymyxin B units
Gramicidin 0.025 mg

It is indicated for superficial infections of the external eye and its adnexa — conjunctivitis, keratitis, blepharitis and related infections caused by susceptible bacteria. Gramicidin's partners are covered in the library's polymyxin B entry; the bacitracin entry covers another peptide antibiotic used on the skin. Because the product combines three drugs, no trial on its label isolates what gramicidin alone contributes.

ClinicalTrials.gov lists 10 studies naming gramicidin (2026-11-17). Two concern eye drops after procedures; three recent ones, phase 1 and phase 2, test Grammidin, a metered-dose throat spray with and without an anaesthetic, the largest planned at 300 participants. Those are records of registered studies, not results.

Where it stands

Gramicidin is an old, narrow, topical antibiotic with one current US use as part of a combination eye drop, and a long second life as a laboratory tool. It is not a research peptide sold for any other purpose. The library's nisin entry covers a peptide antibiotic made by a different bacterium and used in food; peptides for immunity places the antimicrobial peptides side by side.

Sources opened 2026-11-17: Dubos 1939, J Exp Med (PMID 19870884, part I of three); Dubos 1959 retrospective (PMID 13818331, record); gramicidin A channel dimer NMR study (PMID 10805133, record); gramicidin S reviews (PMIDs 30938996, 40683145, records); Kelkar and Chattopadhyay 2007 (PMID 17572379); PubChem CIDs 16132269 and 73357; neomycin, polymyxin B and gramicidin ophthalmic solution label (openFDA, effective 2026-02-04); Drugs@FDA ANDA 064047; PubMed E-utilities and ClinicalTrials.gov API v2 counts.

What the research shows

Kills Gram-positive bacteria

Dubos 1939, J Exp Med (PMID 19870884): agent from a soil bacillus bactericidal to every Gram-positive species tested, ineffective against the Gram-negative bacilli tested

Forms ion channels in membranes

Kelkar and Chattopadhyay 2007, Biochim Biophys Acta review (PMID 17572379): linear gramicidin forms channels specific for monovalent cations

Treats superficial eye infections

Neomycin, polymyxin B and gramicidin ophthalmic solution label (ANDA 064047, Bausch & Lomb; label effective 2026-02-04) — a three-drug combination; gramicidin's own share of the effect is not separated

Bars show how much of the evidence is in humans, not how well anything works.

Where it stands

United States

Neomycin and polymyxin B sulfates and gramicidin ophthalmic solution, ANDA 064047, Bausch & Lomb, prescription (Drugs@FDA). Each mL contains 0.025 mg gramicidin.

Trials

ClinicalTrials.gov: 10 studies name gramicidin (2026-11-17), including three recent ones of a metered-dose throat spray named Grammidin.

Published record

PubMed: 3,746 records with 'gramicidin' in the title or abstract, 18 tagged as randomised controlled trials (2026-11-17).

Frequently asked questions

What is gramicidin?

An antibiotic peptide made by a soil bacterium. The main form, gramicidin A, is a chain of 15 amino acids that makes holes in bacterial membranes. In medicine it is used only on the surface of the body, in the US as part of a prescription eye drop.

How does gramicidin work?

Two gramicidin A molecules join across a membrane and form a narrow channel that lets small positive ions such as sodium and potassium through. Dubos found the agent killed Gram-positive bacteria and did not act on the Gram-negative bacilli he tested.

How is gramicidin used in medicine?

Only on the surface of the body. The one current US product found is a prescription eye solution in which gramicidin is one of three antibiotics, alongside neomycin and polymyxin B, for superficial infections of the eye and eyelid.

Is gramicidin the same as gramicidin S?

No. Gramicidin A, B and C are linear 15-amino-acid chains. Gramicidin S, discovered separately, is a ring of 10 amino acids with a different formula, and it is studied as a separate antibiotic.

What products contain gramicidin?

In the United States, the prescription eye solution that combines neomycin, polymyxin B and gramicidin. Dubos's original agent became tyrothricin, the mixture of gramicidin and tyrocidine; a throat spray named Grammidin is in registered trials.

Who discovered gramicidin?

René Dubos at the Rockefeller Institute, who published the extraction of a bactericidal agent from a soil bacillus in the Journal of Experimental Medicine in 1939.